NCT00912899View on ClinicalTrials.gov

A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Refractory Multiple Myeloma
Interventions
DRUG

Noscapine HCl

Escalating doses given twice per day

Trial Locations (4)

10011

St. Vincent's Comprehensive Cancer Center, New York

10021

Weill Medical College of Cornell University, New York

10032

Columbia Presbyterian Hospital, New York

90024

UCLA, Los Angeles

Sponsors
All Listed Sponsors
lead

Cougar Biotechnology, Inc.

INDUSTRY